MARKET
IPO

MDCX

Medicus Pharma Ltd.
MDCX
NASDAQ
Upcoming IPOs
Expected Listing Date: 2024-10-24
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-
-
-
33.72M~50.59M
-
2024-05-29
Public Filing
View Prospectus
2024-10-01
Offering
Price Range: 4.000~6.00
Shares to be Issued: 1200.00K
2024-10-23
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 8431.19K
2024-10-24
Listed
No Data
About MDCX
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.

Webull offers Medicus Pharma Ltd. stock information, including NASDAQ: MDCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MDCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MDCX stock methods without spending real money on the virtual paper trading platform.